Discrete breakpoint mapping and shortest region of overlap of chromosome arm 1q gain and 1p loss in human hepatocellular carcinoma detected by semiquantitative microsatellite analysis

Genes Chromosomes and Cancer

Volumn 42, Issue 1, 2005, Pages 34-43

  Nishimura, Takafumi ^a   Nishida, Naoshi ^a   Itoh, Teruaki ^a   Komeda, Toshiki ^a   Fukuda, Yoshihiro ^a   Ikai, Iwao ^a   Yamaoka, Yoshio ^b   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Kitano Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CENTROMERE; CHROMOSOME ARM; CHROMOSOME STRUCTURE; CONTROLLED STUDY; CYTOGENETICS; GENE DELETION; GENE MAPPING; GENE TARGETING; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MICROSATELLITE MARKER; ONCOGENE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TUMOR SUPPRESSOR GENE;

ALLELIC IMBALANCE; CARCINOMA, HEPATOCELLULAR; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; GENE AMPLIFICATION; GENETIC MARKERS; HUMANS; LIVER NEOPLASMS; POLYMERASE CHAIN REACTION;

EID: 9644301087     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20117     Document Type: Article

References (33)

1. Amler LC, Bauer A, Corvi R, Dihlmann S, Praml C, Cavenee WK, Schwab M, Hampton GM. 2000. Identification and characterization of novel genes located at the t(1;5)(p36.2;q24) translocation breakpoint in the neuroblastoma cell line NGP. Genomics 64: 195-202.
2. Aspland SE, Bendall, Murre C. 2001. The role of E2A-PBX1 in leukemogenesis. Oncogene 20:5708-5717.
3. Balsara BR, Pei J, De Rienzo A, Simon D, Tosolini A, Lu YY, Shen FM, Fan X, Lin WY, Buetow KH, London WT, Testa JR. 2001. Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1. Genes Chromosomes Cancer 30:245-253.
4. Bentz M, Plesch A, Stilgenbauer S, Doehner H, Lichter P. 1998. Minimal sizes of deletions detected by comparative genomic hybridization. Genes Chromosomes Cancer 21:172-175.
5. Canzian F, Salovaara R, Hemminki A, Kristo P, Chadwick RB, Aaltonen LA, de la Chapelle A. 1996. Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res 56:3331-3337.
6. Chen YJ, Yeh SH, Chen JT, Wu CC, Hsu MT, Tsai SF, Chen PJ, Lin CH. 2000. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology 119:431-440.
7. Collonge-Rame MA, Bresson-Hadni S, Koch S, Carbillet JP, Blagosklonova O, Mantion G, Miguet JP, Heyd B, Bresson JL. 2001. Pattern of chromosomal imbalances in non-B virus related hepatocellular carcinoma detected by comparative genomic hybridization. Cancer Genet Cytogenet 127:49-52.
8. Du Y, Carling T, Fang W, Piao Z, Sheu JC, Huang S. 2001. Hypermethylation in human cancers of the RIZ1 tumor suppressor genes, a member of a histone/protein methyltransferase superfamily. Cancer Res 61:8094-8099.
9. Dyomin VG, Palanisamy N, Lloyd KO, Dyomina K, Jhanwar SC, Houldsworth J, Chaganti RSK. 2000. MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets. Blood 95: 2666-2671.
10. Enomoto H, Ozaki T, Takahashi E, Nomura N, Tabata S, Takahashi H, Ohnuma N, Tanabe M, Iwai J, Yoshida H, Matsunaga T, Sakiyama S. 1994. Identification of human DAN gene, mapping to the putative neuroblastoma tumor suppressor locus. Oncogene 9:2785-2791.
11. Fang W, Piao Z, Simon D, Sheu JC, Huang S. 2000. Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region. Genes Chromosomes Cancer 28: 269-275.
12. Greco A, Miranda C, Pagliardini S, Fusetti L, Bongarzone I, Pierotti A. 1997. Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes. Genes Chromosomes Cancer 19:112-123.
13. Iijima Y, Ito T, Oikawa T, Eguchi M, Kamada N, Kishi K, Asano S, Sakaki Y, Sato Y. 2000. A new ETV6/TEL partner gene, ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation. Blood 95:2126-2131.
14. Iolascon A, Faienza MF, Coppola B, della-Ragione F, Schettini F, Biondi A. 1996. Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16 (INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemias. Leukemia 10:255-260.
15. Kusano N, Shiraishi K, Kubo K, Oga A, Okita K, Sasaki K. 1999. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features. Hepatology 29:1858-1862.
16. Lin YW, Sheu JC, Huang GT, Lee HS, Chen CH, Wang JT, Lee PH, Lu FJ. 1999. Chromosomal abnormality in hepatocellular carcinoma by comparative genomic hybridization in Taiwan. Eur J Cancer 35:652-658.
17. Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, Dejean A. 1997. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 18:59-65.
18. Marchio A, Pineau P, Meddeb M, Terris B, Tiollais P, Bernehim A, Dejean A. 2000. Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients. Oncogene 19:3733-3738.
19. Niketeghad F, Decker HJ, Caselmann WH, Lund P, Geissler F, Dienes HP, Schirmacher P. 2001. Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis. Br J Cancer 85:697-704.
20. Nishida N, Nishimura T, Ito T, Komeda T, Fukuda Y, Nakao K. 2003. Chromosomal instability and human hepatocarcinogenesis. Histol Histopathol 18:897-909.
21. Nishimura T, Nishida N, Itoh T, Kuno M, Minata M, Komeda T, Fukuda Y, Ikai I, Yamaoka Y, Nakao K. 2002. Comprehensive allelotyping of well-differentiated human hepatocellular carcinoma with semiquantitative determination of chromosomal gain or loss. Genes Chromosomes Cancer 35:329-339.
22. Pang E, Wong N, Lai PBS, To KF, Lau JWY, Johnson PJ. 2000. A comprehensive karyotypic analysis on a newly developed hepatocelluar carcinoma cell line, HKCI-1, by spectral karyotyping and comparative genomic hybridization. Cancer Genet Cytogenet 121:9-16.
23. Qin LX, Tang ZY, Sham JST, Ma ZC, Ye SL, Zhou XD, Wu ZQ, Trent JM, Guan XY. 1999. The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma. Cancer Res 59:5662-5665.
24. Sakakura C, Hagiwara A, Taniguchi H, Yamaguchi T, Yamagishi H, Takahashi T, Koyama L, Nakamura Y, Abe T, Inazawa J. 1999. Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization. Br J Cancer 80:2034-2039.
25. Shiraishi K, Okita K, Kusano N, Harada T, Kondoh S, Okita S, Ryozawa S, Ohmura R, Noguchi T, Iida Y, Akiyama T, Atsnori O, Fukumoto Y, Furuya T, Kawauchi S, Sasaki K. 2001. A comparison of DNA copy number changes detected by comparative genomic hybridization in malignancies of the liver, biliary tract, and pancreas. Oncology 60:151-161.
26. Tomillo L, Carafa V, Richter J, Sauter G, Moch H, Minola E, Gambacorta M, Bianchi L, Vecchione R, Terracciano LM. 2000. Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas. J Pathol 192:307-312.
27. Tsushimi T, Noshima S, Oga A, Esato K, Sasaki K. 2001. DNA amplification and chromosomal translocations are accompanied by chromosomal instability: analysis of seven human colon cancer cell lines by comparative genomic hybridization and spectral karyotyping. Cancer Genet Cytogenet 126:34-38.
28. Virtaneva K, Wright FA, Tanner SM, Yuan B, Lemon WJ, Caligiuri MA, Bloomfield CD, de la Chapelle A, Krahe R. 2001. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci USA 98:1124-1129.
29. Wang G, Zhao Y, Liu X, Wang L, Wu C, Zhang W, Liu W, Zhang P, Cong W, Zhu Y, Zhang L, Chen S, Wan D, Zhao X, Huang W, Gu J. 2001. Allelic loss and gain, but not genomic instability, as the major somatic mutation in primary hepatocellular carcinoma. Genes Chromosomes Cancer 31:221-227.
30. Wong N, Lai P, Lee SW, Fan S, Pang E, Liew CT, Sheng Z, Lau JWY, Johnson PJ. 1999. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis; relationship to disease stage, tumor size, and cirrhosis. Am J Pathology 154:37-43.
31. Wong N, Lai P, Pang E, Fung LF, Sheng Z, Wong V, Wang W, Hayashi Y, Perlman E, Yuna S, Lau JWY, Johnson PJ. 2000. Genomic aberrations in human hepatocellular carcinomas of differing etiologies. Clinical Cancer Res 6:4000-4009.
32. Wong N, Lam WC, Lai PBS, Lau WY, Johnson PJ. 2001. Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. Am J Pathol 159:465-471.
33. Yoshikawa H, Nagashima M, Khan MA, McMenamin MG, Hagiwara K, Harris CC. 1999. Mutational analysis of p73 and p53 in human cancer cell lines. Oncogene 18:3415-3421.